MediPal Holdings Corporation (MEPDF)

Market Cap	3.62B
Revenue (ttm)	25.69B
Net Income (ttm)	283.19M
Shares Out	n/a
EPS (ttm)	1.36
PE Ratio	12.79
Forward PE	n/a
Dividend	0.43 (2.69%)
Ex-Dividend Date	Sep 29, 2025

Volume	300
Average Volume	n/a
Open	16.25
Previous Close	15.90
Day's Range	15.90 - 16.25
52-Week Range	13.24 - 17.57
Beta	-0.00
RSI	18.94
Earnings Date	Nov 5, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,061
• Stock Exchange: OTCMKTS
• Ticker Symbol: MEPDF

Financial Performance

In 2024, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial numbers in JPY